> Research Use Only Disclaimer: All products discussed in this article are sold strictly for laboratory research and scientific purposes. They are not approved for human consumption, clinical use, or veterinary application. Always consult applicable regulations before handling research compounds.
Riptide Wellness is a research peptide supplier with 57 active product listings on Peptides.SO. The company stands out for its coverage of advanced metabolic research compounds — including GLP combination analogs, Cagrilintide, Retatrutide-adjacent blends, and multi-compound GLP formulations — that go beyond the standard research peptide catalog.
This review examines Riptide Wellness's compound coverage, pricing, and positioning within the 2026 research peptide market.
Company Overview
Riptide Wellness has developed a catalog that tracks the frontier of metabolic research compound demand. Where many suppliers are still building out basic GLP-1 agonist coverage, Riptide has moved into multi-target metabolic combinations — GLP-3 (Retatrutide), GLP-4 (dual combinations), Cagrilintide/GLP-1 combinations, and the advanced KLOW multi-peptide blend. This positions the company as a supplier oriented toward metabolic research complexity rather than basic catalog depth.
The 57-listing catalog covers tissue repair, melanocortin, cognitive, longevity, GH axis, and metabolic research compounds, making it a broad-category supplier with notable depth in the GLP/metabolic segment.
Catalog Depth and Breadth
Advanced Metabolic Research Compounds
The GLP research compound coverage is among the most advanced of any supplier on Peptides.SO:
- •GLP-3 (Retatrutide) (R) — $109.99–$125.99: The triple GLP-1R/GIPR/GCGR agonist (Eli Lilly LY3437943) in multiple concentrations
- •GLP-4 (5mg/5mg) — $105.99–$109.99: Combination GLP formulation for multi-target metabolic research
- •Cag / GLP1-S — $106.99: Cagrilintide combined with GLP-1 analog for amylin/incretin dual-target protocols
- •CAG 10mg — $89.99: Cagrilintide (amylin analog) for metabolic and appetite regulation research
- •Tesamorelin / Ipamorelin combination — $78.60–$117.00: Multiple dose options for combined GH/metabolic research
- •KLOW Blend 80mg — $104.99: Advanced multi-peptide combination blend
Growth Hormone Secretagogues
GHRP-6 5mg ($39.99), Sermorelin ($89.99), Tesamorelin ($79.49), and CJC-1295/Ipamorelin No DAC Blend ($49.99–$74.99) cover the GH axis research compound set. The Tesamorelin/Ipamorelin combination at multiple price points reflects active catalog management for researchers studying GH-metabolic interactions.
Tissue Repair and Regenerative Peptides
BPC-157 ($44.99), TB-500 Thymosin Beta-4 ($58.99), and BPC-157/TB-500 combination ($70.99) provide standard tissue repair coverage. The PCL GLOW Blend ($79.99) extends into multi-peptide healing compound territory.
Melanocortin Research
MT-1 (Melanotan I, $42.99), MT-2 10mg ($42.99), and PT-141 ($44.99) cover the melanocortin research catalog. The presence of both alpha-MSH receptor agonists indicates a well-rounded approach to melanocortin biology research compound sourcing.
Cognitive and Neuroendocrine Peptides
Semax ($47.99) and Selank ($47.99) cover the two primary neuropeptide research compounds studied in BDNF signaling, neuroprotection, and cognitive biology. DSIP (Delta Sleep Inducing Peptide) at $44.99 extends cognitive/neurological research coverage. VIP 10mg ($89.99) represents the vasoactive intestinal peptide studied in immune regulation and neuroprotection research.
Longevity and Specialty Compounds
Epithalon Pre-Mixed Pen 100mg ($56.99), GHK-Cu 120mg ($49.99), NAD+ ($70.99), 5-Amino-1MQ ($65.85), Pinealon 20mg ($74.99), ARA-290 ($80.99), and MOTS-c ($127.99) represent strong longevity research compound coverage. ARA-290 — the erythropoietin-derived peptide studied in neuroprotection and inflammation research — is a specialty compound rarely available from domestic suppliers.
Reproductive and Hormonal Research
Oxytocin 10mg ($44.99), KissPeptin-10 ($59.99), and HCG 5000iu ($64.99) cover the reproductive neuroendocrinology and hormonal research compound segment.
Metabolic Support and Ancillary
KPV ($65.99), NAD+ ($70.99), Glutathione Rush ($73.99), and IGF-1 LR3 ($76.76) alongside IGF-DES 2mg ($87.99) complete the longevity and cellular metabolism research coverage.
Reconstitution
Bacteriostatic Water in 10mL ($7.50) and 30mL ($22.50) sizes, plus Acetic Acid 0.6% 10mL ($10.00), provide the ancillary products needed for complete research protocols.
COA Standards and Testing Quality
Riptide Wellness provides COA documentation for catalog compounds. The advanced metabolic compound coverage (multi-target GLP combinations, Retatrutide-grade compounds) implies sourcing relationships capable of handling complex synthetic peptides. Researchers should request batch-specific COAs directly from Riptide Wellness for precision protocol applications.
Pricing Analysis
Pricing is competitive, particularly for the advanced metabolic compound segment where Riptide Wellness offers unique multi-compound formulations not widely available from other suppliers.
| Compound | Format | Price |
|---|---|---|
| Bacteriostatic Water | 10mL | $7.50 |
| GHRP-6 | 5mg | $39.99 |
| MT-1 | Standard | $42.99 |
| MT-2 | 10mg | $42.99 |
| BPC-157 | Standard | $44.99 |
| PT-141 | Standard | $44.99 |
| Oxytocin | 10mg | $44.99 |
| Semax | Standard | $47.99 |
| Selank | Standard | $47.99 |
| GHK-Cu | 120mg | $49.99 |
| TB-500 | Standard | $58.99 |
| CAG | 10mg | $89.99 |
| GLP-3 (Retatrutide) | Standard | $109.99 |
Pros and Cons
| Pros | Cons |
|---|---|
| Advanced GLP combination coverage (GLP-3, GLP-4, CAG combos) | No verified badge or rating data on Peptides.SO |
| Unique multi-compound metabolic blends (KLOW, GLP-4) | Location listed as "Unknown" |
| Rare compounds (ARA-290, VIP, DSIP) | Higher pricing on some longevity compounds |
| Competitive entry-level pricing on core compounds | — |
| Strong tissue repair catalog (BPC, TB, GLOW) | — |
| Multiple Tesamorelin/Ipamorelin dosing options | — |
Verdict
Riptide Wellness earns particular distinction for its advanced metabolic research compound catalog. The GLP-3 (Retatrutide), GLP-4 combination formulations, and Cagrilintide/GLP-1 multi-target protocols are genuinely differentiated from what most domestic suppliers offer. Combined with solid core peptide coverage and competitive base pricing on standard compounds, Riptide Wellness is a strong option for researchers working at the frontier of metabolic and GLP receptor biology in 2026.
All products are for laboratory research purposes only. Not for human consumption.
---
Research Context: Riptide Wellness's Advanced Metabolic Compounds
Riptide Wellness's most distinctive catalog entries are the multi-target GLP combinations that go beyond standard semaglutide/tirzepatide. For researchers unfamiliar with these:
GLP-4 (5mg/5mg combination): The designation "GLP-4" is not a standardized pharmacological nomenclature — in the context of research compound suppliers, it typically refers to a combination blend (often a GLP-1/GIP dual formulation or a GLP-1/GIPR/amylin triple blend) that is named to signal the "fourth generation" of incretin-class metabolic research compounds. Researchers should confirm the exact molecular composition of any GLP-4 listing before ordering, as the designation is informal.
CAG / Cag-GLP1-S (Cagrilintide + GLP-1 Analog): Cagrilintide is Novo Nordisk's long-acting amylin analog (designed for once-weekly subcutaneous administration) that targets the amylin receptor system. Combined with a GLP-1 receptor agonist (as in CagriSema, the Phase 3 combination trial), it creates dual-pathway satiety signaling — GLP-1R handles insulin secretion and gastric emptying; amylin receptor handles central satiety signaling and glucagon suppression. The combination produces additive weight reduction exceeding either component alone. See: Cagrilintide Research Profile
ARA-290 (Cibinetide): ARA-290 is an 11-amino-acid peptide derived from the AB loop of erythropoietin (EPO) that specifically activates the innate repair receptor (IRR) — the heterodimer of EPO receptor and beta-common receptor. Unlike full-length EPO, ARA-290 does not trigger erythropoiesis. Research applications center on small-fiber neuropathy, sarcoidosis-associated pain, and anti-inflammatory tissue repair. Its rarity in domestic supplier catalogs reflects limited synthesis infrastructure for EPO-loop peptides. See: ARA-290 compound page
---
Frequently Asked Questions: Riptide Wellness
Q: What is the difference between GLP-3 (Retatrutide) and GLP-4 at Riptide Wellness?
A: "GLP-3" at Riptide Wellness refers to Retatrutide — Eli Lilly's triple GLP-1R/GIPR/GCGR agonist (LY3437943). "GLP-4" is Riptide's own designation for a combination blend that targets additional pathways beyond the triple agonist design; the exact molecular composition should be confirmed directly with the supplier. The GLP-3/Retatrutide listing has a formal clinical pharmacology basis (Phase 3 trials, published Lancet data); the GLP-4 designation is informal and may vary across suppliers who use it. Researchers should request the exact sequence or molecular composition of any GLP-4 listing before use in a mechanistic study. See: Retatrutide Research Profile
Q: Why is ARA-290 described as "rarely available from domestic suppliers"?
A: ARA-290 (the 11-amino-acid EPO-derived innate repair receptor agonist) requires synthesis of a specific loop structure mimicking the AB helix region of the EPO protein. This is technically more demanding than standard linear peptide synthesis and requires manufacturers with experience in biologically active EPO-loop fragments. Most domestic research peptide suppliers source from a limited pool of manufacturers; ARA-290 is not in those manufacturers' standard catalogs, making it a genuine specialty inclusion. Researchers studying neuroprotection, sarcoidosis-related small-fiber neuropathy, or EPO receptor biology who need ARA-290 should confirm current stock before committing to a protocol.
Q: What does "GH-metabolic interaction" research mean for the Tesamorelin/Ipamorelin combination at Riptide Wellness?
A: Tesamorelin is a GHRH analog (GH-releasing hormone analog) that stimulates pituitary somatotrophs to secrete GH, with documented effects on visceral adipose tissue (the basis for its FDA approval in HIV-related lipodystrophy research). Ipamorelin is a GHRP (GH-releasing peptide) that acts on a distinct receptor — ghrelin receptor (GHS-R1a) — to produce GH pulses independent of the GHRH axis. The combination accesses both the primary GH secretory control pathway (GHRH/tesamorelin) and the supplementary pulse-enhancement pathway (ghrelin/ipamorelin), producing synergistic GH elevation greater than either compound alone. This combination format is used in research studying the interaction between GH secretion, visceral fat metabolism, and insulin-like growth factor (IGF-1) biology.
Q: Does Riptide Wellness provide COAs for its advanced combination compounds?
A: Riptide Wellness states it provides COA documentation for catalog products. For combination blends (GLP-4, Cag/GLP1-S, KLOW, PCL GLOW), the COA question is more complex: does the COA characterize each active component in the blend separately, or just the overall formulation? Researchers running mechanistic studies should request component-specific purity data for blends — a single combined HPLC trace may not distinguish between individual compound purity levels. This is particularly important for multi-receptor studies where each component's relative concentration affects the mechanistic interpretation.
Q: Is Riptide Wellness verified on Peptides.SO?
A: Riptide Wellness holds no verified badge on Peptides.SO and has no accumulated platform rating data. The company has no published location listed. For researchers conducting due diligence, the absence of a verified badge means Peptides.SO has not independently confirmed their documentation claims — the COA infrastructure and compound authenticity should be verified through direct supplier engagement and, where appropriate, independent third-party analytical testing of received material.
Q: What is the "Build Your Own 6 Pack" listing and how does it work?
A: Riptide Wellness's "Build Your Own 6 Pack" is a customizable bundle that allows researchers to select 6 compounds from the catalog at a bundle price. This addresses researchers running multi-compound protocols who want to combine healing, metabolic, cognitive, and specialty compounds in a single order — reducing procurement overhead versus individual listing purchases. The per-compound price in the bundle context should be calculated against individual listing prices to confirm the bundle discount. Use the Peptide Stack Builder to plan the compound combination before requesting the bundle.
> All compounds listed are for research use only. Not for human or animal consumption. Research Use Only.